An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 220016
Company: KLM LABS PVT

Products on ANDA 220016

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
MESALAMINE	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 220016

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
03/31/2026	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 220016

MESALAMINE

ENEMA;RECTAL; 4GM/60ML
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
MESALAMINE	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	No	AB	216941	ENCUBE
MESALAMINE	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	No	AB	220016	KLM LABS PVT
MESALAMINE	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	No	AB	215269	NOVITIUM PHARMA
MESALAMINE	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	No	AB	076751	PADAGIS ISRAEL
ROWASA	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	Yes	AB	019618	MYLAN SPECIALITY LP
SFROWASA	MESALAMINE	4GM/60ML	ENEMA;RECTAL	Prescription	Yes	AB	019618	MYLAN SPECIALITY LP

Top